AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About OABI20261016C2.5
Medical service
OmniAb, Inc., was incorporated on December 14, 2015 under the laws of the State of Delaware. The company licenses its proprietary discovery research technology to pharmaceutical and biotechnology partners to support the development of next-generation antibody-based therapies. Its platform utilizes engineered transgenic animals and computer simulation tools to generate and screen a diverse antibody library for drug development.
